Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population
Clinical trial NCT06259669 · RECRUITING
Trial details
- NCT number
- NCT06259669
- Sponsor
- Incyte Corporation
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-09-13
- Primary completion
- 2032-08-01
- Enrollment
- 958
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.